DAAM2 p.Pro556=
c.1668A>C · rs775891415 · VCV3040680
Likely benign
No assertion criteria
Classification
Likely benign
ClinVar
Review
No assertion criteria ☆☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Common
common (popmax 9.93%, amr) — too common for a highly-penetrant pathogenic allele
Conditions
1
DAAM2-related disorder
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -5.4 | GERP -3.8 |
| Overall | ||
| CADD | 0.111 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes
Grpmax group
9.93%
Admixed American · 1,743/17,554 alleles
Filtering AF
9.54%
ClinGen BA1/BS1 input
FAF95, joint · FAF99 9.38%
Overall
3.19%
17,447/547,080 alleles · common
exomes 15,183/509,146 · genomes 2,264/37,934 · joint denominator
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 9.93% | 10 |
| East Asian | 8.68% | 12 |
| South Asian | 8.16% | 12 |
| African / African-American | 5.23% | 19 |
| Ashkenazi Jewishnot grpmax-eligible | 5.15% | 19 |
| Remaining individualsnot grpmax-eligible | 3.79% | 26 |
| Finnishnot grpmax-eligible | 2.62% | 38 |
| European (non-Finnish) | 2.2% | 45 |
| Middle Eastern | 1.77% | 56 |
| Amishnot grpmax-eligible | 1.23% | 81 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- DAAM2
- Protein
- p.Pro556=
- Coding
- c.1668A>C
- MANE Select
- NM_001201427
- dbSNP
- rs775891415
- Type
- single nucleotide variant
- Location
- chr6:39879300 (GRCh38)
- Gene constraint
- LOEUF 0.488 · pLI 0.98 (gnomAD)
- Structure
- AlphaFold pLDDT 80.02
- Residue 556
- a UniProt-annotated variant site (in nphs24; affects the regulation of filopodia formation); the fh1 domain; the 'disordered' region
Disease context
DAAM2-related disorder
Similar variants
- DAAM2 p.Ala829Thr Uncertain significance ⚠ same condition
- DAAM2 p.Glu997Lys Uncertain significance same condition
- DAAM2 p.Gly527Val Uncertain significance ⚠ same condition
- DAAM2 c.1845+7A>G Likely benign same condition
- DAAM2 c.2342-10C>T Likely benign same condition
- DAAM2 c.2983-4G>A Likely benign same condition
- DAAM2 c.2983-8G>C Likely benign same condition
- DAAM2 p.Ala1054Thr Likely benign same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/daam2-p-pro556 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown